DoW Orthopaedic, Clinical Research Award

The Department of Defense, through the U.S. Army Medical Research Acquisition Activity, administers the Orthopaedic Research Program Clinical Research Award to support high-impact clinical research aligned with military health priorities. This funding opportunity is part of a broader federal effort to advance medical research that improves outcomes for Service Members, Veterans, their families, and the general public. The program emphasizes translational and clinical research that can directly inform patient care, clinical guidelines, or healthcare policy, particularly in the area of orthopaedic injuries and conditions. The purpose of this award is to fund clinical research that evaluates orthopaedic-specific interventions, treatments, and outcomes with the goal of reducing the burden of injury and improving recovery trajectories. Applicants are required to clearly demonstrate how their proposed work will influence patient care and produce clinically actionable evidence. The program is structured to support research that not only advances scientific knowledge but also contributes to measurable improvements in treatment strategies, rehabilitation, and long-term patient outcomes. The funding mechanism is divided into two distinct research levels. Research Level 1 supports clinical research studies focused on areas such as ligamentous trauma, osseointegration outcomes, return-to-duty strategies, and military women’s health. Research Level 2 supports clinical trials and includes focus areas such as ligamentous trauma, limb stabilization and protection, and return-to-duty strategies. These tiers reflect increasing levels of complexity and clinical validation, with Level 2 requiring more rigorous trial design and execution. The program does not require cost sharing or matching funds, making it accessible to a broad range of applicants. Eligibility is listed as unrestricted, meaning that any type of entity may apply, subject to further clarification in official application materials. This inclusivity suggests that universities, research institutions, private companies, nonprofits, and potentially other organizations may participate. Applicants must align their proposals with at least one designated focus area and demonstrate relevance to military and civilian orthopaedic care. Applications will be submitted through the appropriate federal systems, typically involving registration with platforms such as Grants.gov and eBRAP. While specific application components are not fully detailed in the forecast, applicants can expect to prepare a comprehensive research proposal including study design, methodology, impact statements, and supporting documentation. Evaluation criteria are expected to focus on scientific merit, clinical relevance, feasibility, and potential impact on patient outcomes. The opportunity is currently forecasted, with an estimated posting date in mid-June 2026 and an anticipated application deadline in mid-November 2026. Awards are expected to be announced by the end of September 2027, with project start dates aligned to that timeline. The total estimated program funding is 13.6 million dollars, with approximately five awards expected. Interested applicants may contact the eBRAP Help Desk via phone or email for technical assistance related to the application process. This funding opportunity appears to be part of an annual or recurring federal research program cycle, although recurrence is not explicitly stated. Based on typical Department of Defense funding patterns, similar opportunities may reappear in future fiscal years. Applicants are encouraged to monitor official program announcements and prepare early to align their research proposals with stated priorities and focus areas.

Ensure alignment with at least one focus area and clearly demonstrate impact on patient care outcomes